ReviewBMJ (Clinical research ed.)2000
Lifestyle medicines.
Review in BMJ (Clinical research ed.), 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Use of generic and essential medicines for prevention and treatment of cardiovascular diseases in Portugal.BMC health services research · 2017Article
- Beyond access to medicines: Eliciting high-income country support for a new global health research and development paradigm.Journal of global health · 2013Review
- How the pill became a lifestyle drug: the pharmaceutical industry and birth control in the United States since 1960.American journal of public health · 2012Article
- [To improve quality healthcare does not imply publicly funding any drug].Atencion primaria · 2012Article
- Lifestyle drugs: concept and impact on society.Indian journal of pharmaceutical sciences · 2010Article
- Asymptotic medicine.Croatian medical journal · 2009Article
- [Lifestyle drugs in medicine].Wiener medizinische Wochenschrift (1946) · 2008Review
- Functional foods: the case for closer evaluation.BMJ (Clinical research ed.) · 2007Article
- Therapeutic innovation in the European Union: analysis of the drugs approved by the EMEA between 1995 and 2003.British journal of clinical pharmacology · 2005Article
- The use of the terms 'lifestyle medicines' or 'lifestyle drugs'.Pharmacy world & science : PWS · 2004Article
- Selling sickness: the pharmaceutical industry and disease mongering.BMJ (Clinical research ed.) · 2002Article
- Lifestyle medicines and the elderly.Drugs & aging · 2002Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.